The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical impact of histologic subtypes and somatic mutations in peritoneal carcinomatosis from colorectal cancer.
Frederic Bibeau
Honoraria - Amgen; Celgene; Merck Serono; Roche
Research Funding - Roche
Expert Testimony - Amgen; Celgene
Amelie Gudin
No relevant relationships to disclose
Amelie Denouel
No relevant relationships to disclose
Lise Roca
No relevant relationships to disclose
Florence Castan
No relevant relationships to disclose
Evelyne Lopez-Crapez
No relevant relationships to disclose
Alexandre Ho-pun-cheung
No relevant relationships to disclose
Pierre-Jean Lamy
No relevant relationships to disclose
Bernard Saint-Aubert
No relevant relationships to disclose
Florence Boissiere
No relevant relationships to disclose
Francois Quenet
No relevant relationships to disclose